Cedelizumab is a monoclonal antibody acting on the immune system. Possible indications include the prevention of organ transplant rejections and the treatment...
3 KB (146 words) - 01:34, 30 May 2023
(Zolimomab aritox) Unsorted Alemtuzumab Anifrolumab Atorolimumab Begelomab Cedelizumab Emapalumab Fontolizumab Inebilizumab Maslimomab Morolimumab Ofatumumab...
7 KB (299 words) - 13:45, 27 April 2024
Immunosuppressive: Apolizumab§ Aselizumab Atezolizumab Benralizumab Camrelizumab† Cedelizumab Certolizumab pegol Crizanlizumab Daclizumab Eculizumab Efalizumab‡ Epratuzumab...
38 KB (4,316 words) - 10:24, 26 August 2024
CEA-Scan CEA-Cide cebaracetam (INN) Ceclor Cecon Cedax cedefingol (INN) cedelizumab (INN) Cedilanid-D cediranib (USAN, INN) Cedocard-SR CeeBU (Bristol-Myers...
10 KB (489 words) - 02:02, 1 July 2024
cBR96-doxorubicin immunoconjugate mab humanized Lewis-Y antigen cancer Cedelizumab mab humanized CD4 prevention of organ transplant rejections, treatment...
136 KB (4,020 words) - 06:13, 27 September 2024
Immunosuppressive: Apolizumab§ Aselizumab Atezolizumab Benralizumab Camrelizumab† Cedelizumab Certolizumab pegol Crizanlizumab Daclizumab Eculizumab Efalizumab‡ Epratuzumab...
2 KB (87 words) - 01:28, 30 May 2023
(Zolimomab aritox) Unsorted Alemtuzumab Anifrolumab Atorolimumab Begelomab Cedelizumab Emapalumab Fontolizumab Inebilizumab Maslimomab Morolimumab Ofatumumab...
38 KB (2,656 words) - 12:11, 30 October 2023